Redox modulation of the fetal cardiovascular defence to hypoxaemia.
Episodes of hypoxia in utero present a potentially serious challenge to the fetus, but are counteracted by defence responses including marked redistribution of blood flow from peripheral circulations to the brain. Here, we report the novel observation that the oxidant tone is an important modulator of this cardiovascular defence. Using pregnant Welsh Mountain sheep surgically prepared for long-term recording, we investigated in vivo the effects on the fetal cardiovascular defence to acute hypoxaemia of fetal treatment with the antioxidant vitamin C. The mechanisms via which vitamin C may affect the vascular oxidant tone were investigated by monitoring fetal plasma concentrations of nitrates and nitrites, by determining changes in the activity of superoxide dismutase (SOD) in fetal plasma, and by investigating the effect of vitamin C treatment on the fetal cardiovascular defence to hypoxaemia following nitric oxide (NO) synthase blockade. Fetal treatment with vitamin C markedly depressed the normal femoral constrictor response to acute hypoxaemia in the fetus (5.2 ± 1.0 vs. 1.1 ± 0.3 mmHg (ml min(-1))(-1), mean ± s.e.m.; P < 0.05) an effect which was completely restored following NO synthase blockade (6.2 ± 1.3 mmHg (ml min(-1))(-1)). Compared to saline infusion, fetal treatment with vitamin C during acute hypoxaemia also significantly increased fetal plasma SOD activity from normoxic baseline (-8.9 ± 6.5 vs. 15.0 ± 6.6% inhibition, P < 0.05) and decreased the plasma concentration ratio of nitrate:nitrite from normoxic baseline (ΔNO3(-):NO2(-); 0.15 ± 0.30 vs. -0.29 ± 0.11, P < 0.05). The data provide in vivo evidence of redox modulation of redistribution of blood flow in the fetus, part of the fetal brain sparing during acute hypoxaemic stress.
Thakor
A S
AS
Department of Physiology, Development and Neuroscience, University of Cambridge, Downing Street, Cambridge CB2 3EG, UK.
Richter
H G
HG
Kane
A D
AD
Dunster
C
C
Kelly
F J
FJ
Poston
L
L
Giussani
D A
DA
D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use; D001205:Ascorbic Acid / Q000097:blood / Q000627:therapeutic use; D001784:Blood Gas Analysis; D002319:Cardiovascular System / Q000503:physiopathology*; D005260:Female; D005333:Fetus / Q000502:physiology*; D000860:Hypoxia / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology*; D023421:Models, Animal; D009566:Nitrates / Q000378:metabolism; D009569:Nitric Oxide / Q000378:metabolism; D009573:Nitrites / Q000378:metabolism; D010084:Oxidation-Reduction; D011247:Pregnancy; D012756:Sheep; D013482:Superoxide Dismutase / Q000378:metabolism
D000975:Antioxidants; D009566:Nitrates; D009573:Nitrites; D009569:Nitric Oxide; D013482:Superoxide Dismutase; D001205:Ascorbic Acid
Biochem Biophys Res Commun. 1975 Mar 17;63(2):463-8
235924
Cancer Res. 2003 Apr 15;63(8):1764-8
12702559
Circ Res. 2003 Oct 3;93(7):622-9
12933702
Circ Res. 1995 May;76(5):922-4
7729011
Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8103-7
7690141
Am J Obstet Gynecol. 1974 Nov 15;120(6):817-24
4429091
Anal Biochem. 1982 Oct;126(1):131-8
7181105
Antimicrob Agents Chemother. 2008 Nov;52(11):4081-8
18710913
Circulation. 1998 Jun 9;97(22):2222-9
9631871
Indian J Physiol Pharmacol. 1989 Jan-Mar;33(1):53-8
2737747
Arch Med Res. 2002 May-Jun;33(3):276-80
12031634
FASEB J. 1993 Sep;7(12):1135-42
8375611
Proc Natl Acad Sci U S A. 1989 Aug;86(16):6377-81
2762330
Pediatr Res. 1993 Jul;34(1):51-5
8356019
Am J Physiol. 1991 Feb;260(2 Pt 1):C219-25
1847583
Lancet. 1979 Nov 24;2(8152):1117-9
91847
BMJ. 1990 Jan 27;300(6719):230-5
2106931
Hypertension. 2000 Apr;35(4):936-41
10775565
Free Radic Biol Med. 1994 Oct;17(4):333-49
8001837
N Engl J Med. 1990 Jul 5;323(1):27-36
2113184
Free Radic Biol Med. 2006 Jan 15;40(2):295-302
16413411
J Dev Physiol. 1984 Feb;6(1):11-9
6707438
J Physiol. 1998 May 15;509 ( Pt 1):297-304
9547402
Circ Res. 1998 Nov 2;83(9):916-22
9797340
Dtsch Tierarztl Wochenschr. 1991 Nov;98(11):424-7
1764986
Circulation. 1997 Jun 17;95(12):2617-22
9193429
Anal Biochem. 2000 Jun 15;282(1):89-93
10860503
Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11771-6
11573011
Am J Physiol Heart Circ Physiol. 2009 Feb;296(2):H237-46
19028797
J Biol Chem. 1999 Mar 19;274(12):8254-60
10075731
Biochim Biophys Acta. 1992 Jan 23;1115(3):201-7
1310874
Biochim Biophys Acta. 1998 Sep 16;1425(1):168-76
9813307
Adv Exp Med Biol. 2010;661:339-54
20204741
J Biol Chem. 1994 Apr 1;269(13):9397-400
8144521
J Physiol. 2001 Dec 1;537(Pt 2):587-96
11731588
J Physiol. 1975 Jun;248(1):15-33
1151803
Endothelium. 2004 Mar-Apr;11(2):109-21
15370070
Bull Exp Biol Med. 2002 Jun;133(6):580-2
12447471
BMJ. 1989 Jul 29;299(6694):279-82
2504405
Sheng Li Xue Bao. 2007 Apr 25;59(2):128-32
17437033
Circulation. 2005 Oct 18;112(16):2510-6
16216959
Am J Physiol Regul Integr Comp Physiol. 2001 Mar;280(3):R678-85
11171645
Biochem Biophys Res Commun. 1993 Jun 30;193(3):1076-82
8323533
Biofactors. 2009 Jan-Feb;35(1):5-13
19319840
N Engl J Med. 1986 Apr 3;314(14):892-902
3513016
Semin Reprod Endocrinol. 1998;16(1):65-73
9654609
Eur J Obstet Gynecol Reprod Biol. 1992 Sep 23;46(2-3):79-86
1451899
Free Radic Biol Med. 2003 Oct 1;35(7):790-6
14583343
Endocrinology. 2000 Nov;141(11):3976-82
11089527
Am J Obstet Gynecol. 1985 Jun 1;152(3):256-60
2408473
Am J Physiol Regul Integr Comp Physiol. 2009 Jan;296(1):R90-9
18922958
Ann Intern Med. 1999 Jul 20;131(2):156-7
10419439
Physiol Rev. 2002 Jan;82(1):47-95
11773609
Respir Physiol Neurobiol. 2007 Jul 1;157(1):45-54
17223613
Int J Vitam Nutr Res. 1987;57(4):411-9
3440716
Anal Biochem. 1984 Aug 15;141(1):238-43
6496931
Circulation. 1997 Sep 2;96(5):1513-9
9315540
J Physiol. 1993 Feb;461:431-49
8350271
Circulation. 1996 Jul 1;94(1):6-9
8964118
Circulation. 2002 Oct 22;106(17):2278-83
12390960
Chem Res Toxicol. 1997 Nov;10(11):1285-92
9403183
Int J Vitam Nutr Res. 1986;56(1):101-3
3710710
J Am Coll Cardiol. 1998 Jul;32(1):103-9
9669256
J Physiol. 2003 Feb 15;547(Pt 1):283-91
12562956
Am J Physiol. 1987 Jan;252(1 Pt 2):R94-101
3101520